ESC Premium Access

Why new target and thresholds?

Topic: Treatment
Sponsored by Menarini Group and Daiichi Sankyo Europe GmbH

Congress Presentation

About the speaker

Doctor Panagiotis K Tsioufis

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

3 more presentations in this session

Why a new treatment algorithm?

Speaker: Professor B. Williams (London, GB)


Why angiotensin II receptor blocker as initial treatment?

Speaker: Professor M. Volpe (Rome, IT)



Speaker: Professor R. Schmieder (Erlangen, DE)


Access the full session

Hypertension management: behind the scenes of 2018 ESH/ESC guidelines

Speakers: Doctor P. Tsioufis, Professor B. Williams, Professor M. Volpe, Professor R. Schmieder

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb